NCCN Expands Resources for Treating Rare Cancer Types

The National Comprehensive Cancer Network publishes two new NCCN Guidelines for Malignant Peritoneal Mesothelioma and for Ampullary Adenocarcinoma, to standardize treatment and improve outcomes for these rare tumor types; also reaches milestone expanding library of NCCN Chemotherapy Order Templates. PLYMOUTH MEETING, Pa., March 9, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—today...

Related Keywords

United States ,Chicago ,Illinois ,Jin Koh ,Facebook Nccnorg ,Bekaii Saabt Ampullary ,Instagram Nccnorg ,National Cancer Institute ,Virtual Library ,National Comprehensive Cancer Network Inc ,Chicago Consensus Working Group ,National Comprehensive Cancer Network ,Malignant Peritoneal Mesothelioma ,Ampullary Adenocarcinoma ,National Comprehensive Cancer ,Practice Guidelines ,Medical Officer Wui Jin Koh ,Systemic Mastocytosis ,Small Cell Lung Cancer ,Cancer App ,Order Templates ,Soc Clin Oncol Educ Book ,Consensus Working ,Chicago Consensus ,Statistics Review ,National Cancer ,Comprehensive Cancer Network ,